Pharmacology and clinical evaluation of nilotinib, a Bcr-Abl tyrosine kinase inhibitor
Machine-generated Keywords：
Publication Date：2008-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 1894-1897 )